Literature DB >> 25005911

Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy.

Amir H Kashani1, Kevin T Brown2, Emmanuel Chang3, Kimberly A Drenser4, Antonio Capone4, Michael T Trese5.   

Abstract

PURPOSE: To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.
DESIGN: Retrospective case series at a single tertiary referral vitreoretinal practice. PARTICIPANTS: A total of 174 eyes of 87 subjects were studied.
METHODS: A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. MAIN OUTCOME MEASURES: Clinical and angiographic findings.
RESULTS: A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.
CONCLUSIONS: Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25005911     DOI: 10.1016/j.ophtha.2014.05.029

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  39 in total

1.  Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I.

Authors:  T R Padhi; T Das; S Rath; L Pradhan; S Sutar; K G Panda; R Modi; S Jalali
Journal:  Eye (Lond)       Date:  2015-11-20       Impact factor: 3.775

2.  The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater.

Authors:  Yue-Zhu Lu; Guang-Da Deng; Jing-Hua Liu; Hong Yan
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

3.  Ultra-wide-field scanning laser ophthalmoscopy assists in the clinical detection and evaluation of asymptomatic early-stage familial exudative vitreoretinopathy.

Authors:  Jiao Lyu; Qi Zhang; Shi-Yuan Wang; Yi-Ye Chen; Yu Xu; Pei-Quan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-14       Impact factor: 3.117

4.  Macular Microvascular Findings in Familial Exudative Vitreoretinopathy on Optical Coherence Tomography Angiography.

Authors:  S Tammy Hsu; Avni P Finn; Xi Chen; Hoan T Ngo; Robert J House; Cynthia A Toth; Lejla Vajzovic
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-05-01       Impact factor: 1.300

5.  TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling.

Authors:  Maria B Lai; Chi Zhang; Jianli Shi; Verity Johnson; Lavan Khandan; John McVey; Michael W Klymkowsky; Zhe Chen; Harald J Junge
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

6.  Early Diagnosis and Management of Aggressive Posterior Vitreoretinopathy Presenting in Premature Neonates.

Authors:  Mrinali P Gupta; Yoshihiro Yonekawa; J Peter Campbell; Irene Rusu; Sarwar Zahid; Samir N Patel; Felix Chau; Karyn E Jonas; Erica Oltra; Anton Orlin; Jonathan Chang; Jason Horowitz; David H Abramson; Brian Marr; Antonio Capone; R V Paul Chan
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-04-01       Impact factor: 1.300

7.  Surgical treatments for fibrous tissue extending to the posterior retina in eyes with familial exudative vitreoretinopathy.

Authors:  Mari Takahashi; Tadashi Yokoi; Satoshi Katagiri; Tomoyo Yoshida-Uemura; Sachiko Nishina; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2017-11-03       Impact factor: 2.447

8.  Persistent vasa hyaloidea propria/retinae in familial exudative vitreoretinopathy.

Authors:  Eric D Gaier; Yoshihiro Yonekawa
Journal:  J AAPOS       Date:  2020-12-21       Impact factor: 1.220

9.  Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children.

Authors:  G Baker Hubbard; Alexa L Li
Journal:  Am J Ophthalmol       Date:  2020-07-21       Impact factor: 5.258

Review 10.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.